Biosimilars in the EU
The EU has pioneered the regulation of biosimilar medicines by establishing a solid framework for their approval and by shaping biosimilar development globally. Since the EU approved the first biosimilar in 2006, healthcare professionals have gained increasing experience with their use. Today, biosimilars are
Download Biosimilars in the EU
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
UK-EU TRADE AND COOPERATION AGREEMENT
assets.publishing.service.gov.ukselling into the EU and will support the mobility of UK professionals who will continue to do business across the EU. 4. The Agreement firmly and explicitly recognises UK sovereignty over our fishing waters and puts us in a position to rebuild our fishing fleet and increase quotas in the next few years, finally overturning the inequity that
For Healthcare Professionals: END OF LIFE GUIDANCE FOR ...
diabetes-resources-production.s3.eu-west-1.amazonaws.comHealthcare professionals need to be trained and competent to care for this population, therefore, an additional section on training and education of the healthcare workforce is included 1 . This updated guidance summarises the major clinical problems that individuals with diabetes at the end of life experience and how
Diabetes care during the NHS response to the Omicron ...
diabetes-resources-production.s3.eu-west-1.amazonaws.comhealthcare professionals who work with them every day. How GPs can support people with diabetes • Be aware of diabetes-related complications and people presenting with: Difficulties with blood glucose control or symptoms worse than normal (4Ts – toilet, thirsty, tired, thinner). New or worsening foot or eye problems.
THE EUROPEAN DATA STRATEGY - European Commission
ec.europa.eu€5 billion in healthcare costs globally. Jet engines filled with thousands of sensors collect and transmit data back to ensure efficient operation. Wind farms use industrial data to reduce visual impact ... The number of data professionals (EU27) Percentage of EU population
Infection prevention and control for the care of patients ...
www.ecdc.europa.euUse of gloves by health professionals to prevent COVID-19 transmission In healthcare settings, the use of gloves is part of standard infection prevention and control (IPC) measures and is recommended as part of the standard precautions when there is a risk of contact with body fluids, including during
Forxiga (dapagliflozin) 5mg should no ... - ema.europa.eu
www.ema.europa.euHealthcare professionals should continue to report adverse reactions associated with the use of dapagliflozin in accordance with the national spontaneous reporting system <include the . details. (e.g. name, postal address, fax number, website address) on how to access the